TLX · Telix Pharmaceuticals Ltd · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-09-07 | Smith Darren Charlton |
Group Chief Financial Officer |
Buy↑
Filing footnotes — Ordinary Shares (Direct)
Represents shares purchased by the Reporting Person under the Employee Share Purchase Plan section of the Issuer's Equity Incentive Plan ("AU ESPP"), which shares were allocated on September 7, 2026, based on the Reporting Person's contributions to the AU ESPP from January 1, 2026 - June 30, 2026. Purchase price is recorded in Australian Dollars. |
Ordinary Shares
|
2,071 |
| 2026-04-29 | Behrenbruch Christian |
Director, MD & Group CEO |
Buy↑
Filing footnotes — Ordinary Shares (Indirect)
The purchase prices are reported in Australian Dollars. The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.54 - $14.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (4) to this Form 4. Dr. Behrenbruch is the sole director and shareholder of Elk River Holdings Pty Ltd. |
Ordinary Shares
(I)
|
33,435 |
| 2026-04-28 | Behrenbruch Christian |
Director, MD & Group CEO |
Buy↑
Filing footnotes — Ordinary Shares (Indirect)
The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.42 - $14.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (SEC), upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. The purchase prices are reported in Australian Dollars. Dr. Behrenbruch is the sole director and shareholder of Elk River Holdings Pty Ltd. |
Ordinary Shares
(I)
|
34,500 |
| 2026-03-29 | Smith Darren Charlton |
Group Chief Financial Officer |
Convert↓
Filing footnotes — Share Rights (Direct)
The share rights (SRs) were granted on January 1, 2025 and became vested and exercisable on March 5, 2026. |
Share Rights
|
1,111 |
| 2026-03-29 | Smith Darren Charlton |
Group Chief Financial Officer |
Convert↑
|
Ordinary Shares
|
1,111 |